MeMed

Meet Ron: A Toddler's Battle with Fever & Cough In the thick of respiratory illness season, 14-month-old Ron develops fever, runny nose, and a productive cough. A visit to the ER reveals no alarming signs, and rapid testing helps guide his diagnosis. 🔬 Flu A positive, MeMed BV viral score of 8 ✅ Viral infection confirmed, bacterial co-infection ruled out   🏠 Discharged home for recovery Rapid, accurate diagnostics can make all the difference—helping avoid unnecessary hospital stays and invasive tests. https://lnkd.in/dByuyHYp #Pediatrics #Diagnostics #RespiratoryIllness #hostresponse

The scenario is all too common... Your child is sick with a high fever. Is it #bacterial or #viral? The uncertainty can be stressful, leading to unnecessary antibiotics or delayed treatment. If only #MeMedBV had been used... A smarter, faster way to guide decisions- helping doctors reduce uncertainty and provide the smarter treatment, at the right time.

After a wave of scientific publications supporting BV clinical evidence, we now delve deep into the cost-effectiveness of MeMed BV in latest study—uncovering how this novel host-response test could improve the management of community-acquired pneumonia (CAP) in the UK. CAP remains a leading cause of hospital admissions and mortality, and rapid, accurate differentiation between bacterial and viral infections is crucial for better patient outcomes and antimicrobial stewardship. The following UK health economics study (Gregg E et al, JAC-AMR) evaluated the potential cost impact of integrating MMBV into clinical decision-making, and the results are compelling:  ✔️ Demonstrated Potential Cost Savings – MeMed BV implementation could save £134,018 for adults and £105,750 for children per 1,000 CAP patients. ✔️Optimized Antibiotic Use – Reducing unnecessary antibiotic treatments, a key step in combating antimicrobial resistance. ✔️Fewer Hospital Admissions & Diagnostic Tests – More efficient resource utilization, benefiting both healthcare systems and patients. This study reinforces that MeMed BV is not only clinically valuable but can also be a cost-saving solution that supports smarter antibiotic decisions in both adult and pediatric CAP management. Let’s keep the discussion going—how do you see host-response diagnostics influencing the future of healthcare? https://lnkd.in/dRCKM2VG #HealthcareInnovation #AntimicrobialStewardship #CostEffectiveness #Diagnostics #Pneumonia #MMBV #HealthEconomics #hostresponse

With the growing body of clinical evidence supporting MeMed BV, we’re highlighting today a key study published in Clinical Infectious Diseases (CID) that introduces a novel adjudication-based reference standard for infection etiology across multiple cohorts, including difficult-to-diagnose cases. One of the standout findings from this study was how MeMed BV maintained high diagnostic accuracy even in the most challenging cases, reinforcing its reliability in clinical decision-making and highlighting the critical need for standardized reference methods to ensure accurate diagnostic comparisons. Stay tuned as we dive into more research insights! https://lnkd.in/dcMKb8wD #Diagnostics #InfectionEtiology #HealthcareInnovation #PatientCare #MeMedBV #hostresponse 

With the growing body of clinical evidence showcasing the benefits of MeMed BV, we’re dialing into a key study by Kalmovich et al., published in BMC Medicine (2025). This study, conducted across 10 urgent care centers, 144 physicians, and 3,920 patients, demonstrated how MeMed BV optimizes antibiotic use, improves bacterial infection identification, and significantly reduces emergency department (ED) referrals. One of the standout findings from this study was how MeMed BV influenced patient management, preventing unnecessary ED visits. ✅ 20.5% of patients avoided unnecessary ED referrals based on MeMed BV results ✅ MeMed BV contributed to 3.6% of referrals, ensuring high-risk patients received timely care ✅ Results were consistent across different age groups and diagnoses By providing clear, actionable insights when traditional biomarkers like WBC and CRP were inconclusive, MeMed BV empowered physicians to make more confident, data-driven decisions—reducing the burden on emergency departments while ensuring patients received the right care at the right time. As healthcare systems continue to face increasing pressures, real-world evidence like this highlights the operational and clinical value of advanced diagnostic tools like MeMed BV. Stay tuned as we explore more findings from recent research! #AntibioticStewardship #Diagnostics #HealthcareInnovation #EmergencyMedicine #MeMed https://lnkd.in/dzW_Tdjb

When strong clinical evidence supports your work, it reinforces both its value and the responsibility to keep pushing forward. At MeMed, we’re grateful to see three additional newly published, peer-reviewed studies further supporting the clinical, operational, and financial benefits of MeMed BV. Conducted across the U.S., Europe, and the U.K., these studies showcase diverse advantages of MeMed BV, including improved antibiotic stewardship, superior performance over the standard of care, and reduced healthcare costs. 🔬 Key Findings: • Optimized antibiotic use and reduced hospitalizations in a multi-center, real-world study, with a 63% drop in unnecessary antibiotic prescriptions, help preventing ED referrals in 20% of the patients. (Kalmovich et al, BMC Medicine) • Outperformed the standard of care, even in challenging, hard-to-diagnose cases (Allen et al, Clinical Infectious Diseases). • Demonstrated cost savings in both adult and pediatric patients in a dedicated UK health economics study (Gregg E et al, JAC-AMR). MeMed is committed to advancing research and evidence-based medicine, providing clinicians with the best tools for informed decisions. Read more [https://lnkd.in/d4nY_9Rp] #Diagnostics #ClinicalEvidence #MeMedBV #AntibioticStewardship #TheHostResponseCompany

We're #hiring a new Clinical Specialist in Haifa District. Apply today or share this post with your network.

We're #hiring a new Clinical Specialist in Haifa District. Apply today or share this post with your network.

We're #hiring a new Verification and Validation (V&V) Team Leader in Haifa District. Apply today or share this post with your network.

We're #hiring a new Verification and Validation (V&V) Team Leader in Haifa District. Apply today or share this post with your network.